Copyright
©The Author(s) 2015.
World J Hepatol. Nov 18, 2015; 7(26): 2648-2663
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2648
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2648
Table 4 Organ Procurement and Transplantation Networks classification system for nodules seen on images of cirrhotic livers
OPTN class 0 | |
Incomplete or technically inadequate study | Repeat study required for adequate assessment; automatic priority MELD points cannot be assigned on basis of an imaging study categorized as OPTN class 0 |
OPTN class 5 | |
Meets radiologic criteria for HCC | May qualify for automatic exception, depending on stage |
Class 5A: ≥ 1 cm and < 2 cm measured on late arterial or portal venous phase images | Increased contrast enhancement in late hepatic arterial phase AND washout during later phases of contrast enhancement AND peripheral rim enhancement (capsule or pseudocapsule) |
Class 5A-g: Same size as OPTN class 5A HCC | Increased contrast enhancement in late hepatic arterial phase AND growth by 50% or more documented on serial CT or MR images obtained ≤ 6 mo apart |
Class 5B: Maximum diameter ≥ 2 cm and ≤ 5 cm | Increased contrast enhancement in late hepatic arterial phase AND either washout during later contrast phases OR peripheral rim enhancement (capsule or pseudocapsule) OR growth by 50% or more documented on serial CT or MR images obtained ≤ 6 mo apart (OPTN class 5B-g) |
Class 5T: Prior regional treatment for HCC | Describes any residual lesion or perfusion defect at site of prior UNOS class 5 lesion |
Class 5X: Maximum diameter ≥ 5 cm | Increased contrast enhancement in late hepatic arterial phase AND either washout during later contrast phases OR peripheral rim enhancement (capsule or pseudocapsule) |
- Citation: Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7(26): 2648-2663
- URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2648.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i26.2648